The evolution of acute lymphoblastic leukemia research and therapy at MD Anderson over four decades
Progress in the research and therapy of adult acute lymphoblastic leukemia (ALL) is
accelerating. This analysis summarizes the data derived from the clinical trials conducted at …
accelerating. This analysis summarizes the data derived from the clinical trials conducted at …
The treatment of Burkitt lymphoma in adults
J Crombie, A LaCasce - Blood, The Journal of the American …, 2021 - ashpublications.org
Burkitt lymphoma (BL) is a highly aggressive, B-cell, non-Hodgkin lymphoma categorized
into endemic, sporadic, and immunodeficiency-associated subtypes. BL has distinct …
into endemic, sporadic, and immunodeficiency-associated subtypes. BL has distinct …
Single-route CNS prophylaxis for aggressive non-Hodgkin lymphomas: real-world outcomes from 21 US academic institutions
VM Orellana-Noia, DR Reed… - Blood, The Journal …, 2022 - ashpublications.org
Prophylaxis is commonly used to prevent central nervous sy stem (CNS) relapse in diffuse
large B-cell lymphoma (DLBCL), with no clear standard of care. We retrospectively …
large B-cell lymphoma (DLBCL), with no clear standard of care. We retrospectively …
EBV and Lymphomagenesis
DG Sausen, A Basith, S Muqeemuddin - Cancers, 2023 - mdpi.com
Simple Summary Epstein–Barr virus is a highly prevalent virus associated with a multitude of
diseases, including autoimmune conditions such as multiple sclerosis and many types of …
diseases, including autoimmune conditions such as multiple sclerosis and many types of …
Defining and treating high-grade B-cell lymphoma, NOS
High-grade B-cell lymphoma (HGBL), not otherwise specified (NOS), is a recently introduced
diagnostic category for aggressive B-cell lymphomas. It includes tumors with Burkitt-like or …
diagnostic category for aggressive B-cell lymphomas. It includes tumors with Burkitt-like or …
HIV-associated Burkitt lymphoma: outcomes from a US-UK collaborative analysis
Data addressing prognostication in patients with HIV related Burkitt lymphoma (HIV-BL)
currently treated remain scarce. We present an international analysis of 249 (United States …
currently treated remain scarce. We present an international analysis of 249 (United States …
Adult Acute Lymphoblastic Leukemia Treatment (PDQ®): Health Professional Version
PDQATE Board - PDQ Cancer Information Summaries …, 2002 - pubmed.ncbi.nlm.nih.gov
This PDQ cancer information summary for health professionals provides comprehensive,
peer-reviewed, evidence-based information about the treatment of acute lymphoblastic …
peer-reviewed, evidence-based information about the treatment of acute lymphoblastic …
[HTML][HTML] Outcomes of Burkitt lymphoma with central nervous system involvement: evidence from a large multicenter cohort study
Central nervous system (CNS) involvement in Burkitt lymphoma poses a major therapeutic
challenge, and the relative ability of contemporary regimens to treat CNS involvement …
challenge, and the relative ability of contemporary regimens to treat CNS involvement …
Burkitt's lymphoma
M Roschewski, LM Staudt… - New England Journal of …, 2022 - Mass Medical Soc
Burkitt’s Lymphoma | New England Journal of Medicine Skip to main content The New England
Journal of Medicine homepage Advanced Search SEARCH SPECIALTIES Cardiology Clinical …
Journal of Medicine homepage Advanced Search SEARCH SPECIALTIES Cardiology Clinical …
How I treat secondary CNS involvement by aggressive lymphomas
JP Alderuccio, L Nayak, K Cwynarski - Blood, 2023 - ashpublications.org
Secondary central nervous system (CNS) lymphoma (SCNSL) is a rare but clinically
challenging scenario with historically disappointing outcomes. SCNSL refers to lymphoma …
challenging scenario with historically disappointing outcomes. SCNSL refers to lymphoma …